X
ACHEMA MIDDLE EAST 2026
Pharma Advancement
DDF Summit 2025
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    idiopathic pulmonary fibrosis

    US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

    Tissue Repair Drug

    FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

    FastTrack Review

    US FDA Launches Fast-Track Review Scheme for Generic Drugs

    AI Based Drug Discovery

    Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

    wearable drug delivery devices

    Wearable Drug Delivery Devices for On-Demand Care

    biologic drug formulation stability

    Breakthroughs in Biologic Drug Formulation Stability

    high volume injectable formulations

    Overcoming Challenges in High-Volume Injectable Formulations

    lipid nanoparticles in RNA therapies

    Lipid Nanoparticles in RNA and Gene Therapies

    Breast Cancer Therapy

    US FDA Approves Breast Cancer Therapy Inluriyo by Eli Lilly

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    idiopathic pulmonary fibrosis

    US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

    Tissue Repair Drug

    FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

    FastTrack Review

    US FDA Launches Fast-Track Review Scheme for Generic Drugs

    AI Based Drug Discovery

    Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

    wearable drug delivery devices

    Wearable Drug Delivery Devices for On-Demand Care

    biologic drug formulation stability

    Breakthroughs in Biologic Drug Formulation Stability

    high volume injectable formulations

    Overcoming Challenges in High-Volume Injectable Formulations

    lipid nanoparticles in RNA therapies

    Lipid Nanoparticles in RNA and Gene Therapies

    Breast Cancer Therapy

    US FDA Approves Breast Cancer Therapy Inluriyo by Eli Lilly

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Press Statements

Opioid Addiction Management – A Study On Pharmacists Role

Content Team by Content Team
21st May 2024
in Press Statements
Opioid Addiction Management – A Study On Pharmacists Role

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Pharmacists in the times that we are in happen to play a very critical role considering the magnitude of drugs and their respective outcomes. There are drugs that can as well be pretty addictive like the ones having opioids and therefore it is significant to observe the role of pharmacists in dealing with them as they are the point of contact for a patient.

A groundbreaking study titled “The Role of Pharmacists in Addiction Management of Opioids” by Pallav Dave, a regulatory compliance analyst based in Kentucky, has shed light on the critical role that pharmacists play in addressing the opioid crisis. The paper explores various aspects of pharmacists’ involvement in managing opioid addiction, emphasizing prevention, screening, education, naloxone distribution, counseling, and referral to treatment resources.

Key Findings and Impact

The study provides a comprehensive overview of the current state of the opioid crisis in the United States, backed by recent data on prevalence and opioid-related deaths. According to the 2022 National Survey on Drug Use and Health, 8.9 million people aged 12 and older misused opioids, with 6.1 million diagnosed with an opioid use disorder. The alarming increase in opioid overdose deaths, which reached approximately 70,000 in 2020, underscores the urgent need for effective addiction management strategies.

Pharmacists, due to their unique position in the healthcare system, are ideally suited to play a significant role in opioid addiction management. The study highlights several key areas where pharmacists can make a difference:

Prevention: Pharmacists can utilize models like SBIRT (Screening, Brief Intervention, and Referral to Treatment) to screen patients for opioid use disorder (OUD), initiate discussions about opioid use, and provide early interventions.

Education: Education-based interventions by pharmacists have shown positive outcomes in preventing opioid misuse and abuse. Pharmacists are well-placed to educate patients and healthcare providers about the risks of opioid misuse and the importance of safe opioid use.

Naloxone Distribution: Pharmacists play a crucial role in distributing naloxone, a life-saving medication that can reverse opioid overdoses. Community pharmacies serve as accessible points for naloxone distribution, significantly contributing to overdose prevention efforts.

DOWNLOAD THE STUDY HERE

Medication-Assisted Treatment (MAT): Pharmacists can support MAT programs by dispensing FDA-approved medications like methadone, naltrexone, and buprenorphine, which are proven to be effective in treating opioid addiction and reducing fatal overdoses.

Counseling and Referral: Pharmacists can provide counseling on the risks of opioid misuse, safe storage, and disposal of opioids. They can also refer patients to addiction treatment resources and support adherence to treatment programs.

The misuse of opioid through a medication is a worry that can indeed to an extent be curtailed says the study with the pharmacists bent and knowledge towards doing so.

The study underscores the potential of pharmacists to transform opioid addiction management through comprehensive and interdisciplinary approaches. By leveraging their expertise in medication safety and management, pharmacists can significantly reduce the incidence of opioid misuse and improve patient outcomes.

Author Information

Pallav Dave is a regulatory compliance analyst with extensive experience in the pharmaceutical industry. Based in Kentucky, Pallav specializes in ensuring compliance with healthcare regulations and enhancing medication safety practices. With a deep commitment to public health, Pallav has conducted extensive research on opioid addiction management, focusing on pharmacists’ pivotal role in combating the opioid crisis. Pallav Dave continues to contribute to advancements in regulatory compliance and addiction management.

Previous Post

Robust Supply Chains Are Essential For Affordable Drugs

Next Post

Growing Market Size - US Clinical Trials Supply & Logistics

Related Posts

Packaging & Logistic

VarioFill: Rotzinger sets new standards with highly flexible filling and capping platform for OTC products

30th August 2025
Major Depressive Disorder
Americas

AbbVie to Acquire Gilgamesh Pharmaceuticals’ Bretisilocin, a Novel, Investigational Therapy for Major Depressive Disorder, Expanding Psychiatry Pipeline

27th August 2025
Schott-Testing
Press Statements

Carbon Reduced Pharmaceutical Glass: SCHOTT Melting Tank Construction Starts and External Certification for FIOLAX® Pro OCF

11th August 2025
GSK and Hengrui Pharma
Drug Development

GSK and Hengrui Pharma enter agreements to develop up to 12 innovative medicines across Respiratory, Immunology & Inflammation and Oncology

29th July 2025
Aptar Pharma Bolsters Clinical Trial.
Clinical Trials

Aptar Pharma Bolsters Clinical Trial Capabilities with Strategic Materials Manufacturing Acquisition

24th July 2025
Pharma Advancement Banner
Press Statements

Welcome to the Inaugural Operationalize: Expanded Access Programs Summit West

27th June 2025
Next Post

Growing Market Size - US Clinical Trials Supply & Logistics

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Subscribe Us

System

  • Search
  • Sitemap
  • RSS Feed

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack
  • Newsletters Archive

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Articles
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In